Replies to post #659547 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

Thanks for sharing this information.

It’s very exciting and encouraging that NWBio may be able to use Real World Data (RWD) and Real World Evidence (RWE) in future basket trials, treating multiple solid tumor cancer types, to obtain accelerated tissue agnostic regulatory approvals for both DCVax-L and DCVax Direct, to treat all or most solid tumor cancers.

Then, after the initial accelerated approvals, NWBio will also plan Phase IV post-approval confirmatory trials to permanently maintain those approvals.